Cidara Therapeutics, Inc. Quarterly Other Assets, Noncurrent in USD from Q4 2014 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of noncurrent assets classified as other.
Summary
Cidara Therapeutics, Inc. quarterly Other Assets, Noncurrent history and growth rate from Q4 2014 to Q2 2024.
  • Cidara Therapeutics, Inc. Other Assets, Noncurrent for the quarter ending June 30, 2024 was $104K, a 90.2% decline year-over-year.
Other Assets, Noncurrent, Quarterly (USD)
Other Assets, Noncurrent, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $104K -$957K -90.2% Jun 30, 2024 10-Q 2024-08-13
Q1 2024 $987K -$74K -6.98% Mar 31, 2024 10-Q 2024-05-15
Q4 2023 $114K -$958K -89.4% Dec 31, 2023 10-Q 2024-08-13
Q3 2023 $1.05M -$242K -18.7% Sep 30, 2023 10-K 2024-04-22
Q2 2023 $1.06M +$48K +4.74% Jun 30, 2023 10-K 2024-04-22
Q1 2023 $1.06M +$42K +4.12% Mar 31, 2023 10-K 2024-04-22
Q4 2022 $1.07M -$12K -1.11% Dec 31, 2022 10-K 2024-04-22
Q3 2022 $1.3M +$121K +10.3% Sep 30, 2022 10-K 2024-04-22
Q2 2022 $1.01M -$948K -48.3% Jun 30, 2022 10-K 2024-04-22
Q1 2022 $1.02M -$942K -48% Mar 31, 2022 10-K 2024-04-22
Q4 2021 $1.08M -$939K -46.4% Dec 31, 2021 10-K 2023-03-23
Q3 2021 $1.17M -$849K -42% Sep 30, 2021 10-Q 2021-11-10
Q2 2021 $1.96M +$326K +19.9% Jun 30, 2021 10-Q 2021-08-12
Q1 2021 $1.96M +$326K +19.9% Mar 31, 2021 10-Q 2021-05-13
Q4 2020 $2.02M +$922K +83.7% Dec 31, 2020 10-K 2022-03-07
Q3 2020 $2.02M +$121K +6.36% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 $1.64M +$189K +13.1% Jun 30, 2020 10-Q 2020-08-13
Q1 2020 $1.64M +$364K +28.6% Mar 31, 2020 10-Q 2020-05-13
Q4 2019 $1.1M -$170K -13.4% Dec 31, 2019 10-K 2021-02-25
Q3 2019 $1.9M +$1.84M +2968% Sep 30, 2019 10-Q 2019-11-08
Q2 2019 $1.45M +$1.26M +661% Jun 30, 2019 10-Q 2019-08-08
Q1 2019 $1.27M +$950K +296% Mar 31, 2019 10-Q 2019-05-09
Q4 2018 $1.27M +$950K +296% Dec 31, 2018 10-K 2020-03-04
Q3 2018 $62K -$128K -67.4% Sep 30, 2018 10-Q 2018-11-08
Q2 2018 $190K $0 0% Jun 30, 2018 10-Q 2018-08-09
Q1 2018 $321K +$131K +68.9% Mar 31, 2018 10-Q 2018-05-10
Q4 2017 $321K +$131K +68.9% Dec 31, 2017 10-K 2019-02-28
Q3 2017 $190K $0 0% Sep 30, 2017 10-Q 2017-11-08
Q2 2017 $190K $0 0% Jun 30, 2017 10-Q 2017-08-09
Q1 2017 $190K +$118K +164% Mar 31, 2017 10-Q 2017-05-10
Q4 2016 $190K +$118K +164% Dec 31, 2016 10-K 2018-02-27
Q3 2016 $190K +$117K +160% Sep 30, 2016 10-Q 2016-11-10
Q2 2016 $190K +$118K +164% Jun 30, 2016 10-Q 2016-08-11
Q1 2016 $72K -$1.5M -95.4% Mar 31, 2016 10-Q 2016-05-12
Q4 2015 $72K -$402K -84.8% Dec 31, 2015 10-K 2017-03-15
Q3 2015 $73K Sep 30, 2015 10-Q 2015-11-16
Q2 2015 $72K Jun 30, 2015 10-Q 2015-08-11
Q1 2015 $1.57M Mar 31, 2015 10-Q 2015-05-21
Q4 2014 $474K Dec 31, 2014 10-K 2016-03-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.